首页> 外文期刊>Journal of proteome research >Label-free proteomics and systems biology analysis of mycobacterial phagosomes in dendritic cells and macrophages
【24h】

Label-free proteomics and systems biology analysis of mycobacterial phagosomes in dendritic cells and macrophages

机译:树突状细胞和巨噬细胞中分枝杆菌吞噬体的无标记蛋白质组学和系统生物学分析

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Proteomics has been applied to study intracellular bacteria and phagocytic vacuoles in different host cell lines, especially macrophages (Mφs). For mycobacterial phagosomes, few studies have identified over several hundred proteins for systems assessment of the phagosome maturation and antigen presentation pathways. More importantly, there has been a scarcity in publication on proteomic characterization of mycobacterial phagosomes in dendritic cells (DCs). In this work, we report a global proteomic analysis of Mφ and DC phagosomes infected with a virulent, an attenuated, and a vaccine strain of mycobacteria. We used label-free quantitative proteomics and bioinformatics tools to decipher the regulation of phagosome maturation and antigen presentation pathways in Mφs and DCs. We found that the phagosomal antigen presentation pathways are repressed more in DCs than in Mφs. The results suggest that virulent mycobacteria might co-opt the host immune system to stimulate granuloma formation for persistence while minimizing the antimicrobial immune response to enhance mycobacterial survival. The studies on phagosomal proteomes have also shown promise in discovering new antigen presentation mechanisms that a professional antigen presentation cell might use to overcome the mycobacterial blockade of conventional antigen presentation pathways.
机译:蛋白质组学已被用于研究不同宿主细胞系,特别是巨噬细胞(Mφ)中的细胞内细菌和吞噬液泡。对于分枝杆菌吞噬体,很少有研究鉴定出数百种蛋白质用于吞噬体成熟和抗原呈递途径的系统评估。更重要的是,关于树突状细胞(DCs)中分枝杆菌吞噬体的蛋白质组学表征的出版物很少。在这项工作中,我们报告了感染了分枝杆菌的强毒,减毒和疫苗株的Mφ和DC吞噬体的全球蛋白质组学分析。我们使用了无标签的定量蛋白质组学和生物信息学工具来破译Mφ和DC中吞噬体成熟和抗原呈递途径的调控。我们发现吞噬体抗原呈递途径在DC中比在Mφ中受到更多的抑制。结果表明,强力分枝杆菌可能会选择宿主免疫系统来刺激肉芽肿的形成,从而持续存在,同时将抗菌免疫反应降至最低,以提高分枝杆菌的存活率。吞噬体蛋白质组学的研究还显示出有望发现新的抗原呈递机制,专业的抗原呈递细胞可以用来克服常规抗原呈递途径的分枝杆菌阻滞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号